-
Hepatocellular Carcinoma
3032322
global
1
1.25
9
1.25
1.25
Clinical Review
0
1
Hematology-Oncology2023-03-30 20:00:00
How do you manage your patients with cholangiocarcinoma?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
1.25
9
1.25
2
1.25
3
1.25
1.25
Roundtable
0
1
Hematology-Oncology2023-03-29 20:00:00
Eager to learn more about managing small cell lung cancer (SCLC)? Get ready with these cutting-edge talks.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Lipids Management
5000182
global
1
0.5
9
0.5
0.5
Commentary
0
1
Cardiology2023-03-29 20:00:00
Do you know how to leap the barriers of access and adherence to proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and how to get your patients to goal?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Dermatitis
8
global
1
1.0
9
1.0
1.0
Roundtable
0
1
Dermatology2023-03-29 20:00:00
Are you consistently managing your patients with moderate to severe atopic dermatitis (AD) or treating the flares as they come?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Pulmonary Arterial Hypertension
417
global
1
1.0
1.0
Clinical Review
0
1
Cardiology2023-03-29 20:00:00
Through the lens of SDoH, this program will explore the burdens many PAH patients face including access to care and prejudices real or perceived.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Acute Heart Failure (HF)
6006394
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Cardiology2023-03-29 20:00:00
Preventing rehospitalization for heart failure (HF) is key. Listen as our experts discuss the latest evidence for optimizing medical therapy for better patient outcomes.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Hepatocellular Carcinoma
3032322
global
1
1.25
9
1.25
1.25
Clinical Review
0
1
Hematology-Oncology2023-03-30 20:00:00
How do you manage your patients with cholangiocarcinoma?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
1.25
9
1.25
2
1.25
3
1.25
1.25
Roundtable
0
1
Hematology-Oncology2023-03-29 20:00:00
Eager to learn more about managing small cell lung cancer (SCLC)? Get ready with these cutting-edge talks.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Lipids Management
5000182
global
1
0.5
9
0.5
0.5
Commentary
0
1
Cardiology2023-03-29 20:00:00
Do you know how to leap the barriers of access and adherence to proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and how to get your patients to goal?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Dermatitis
8
global
1
1.0
9
1.0
1.0
Roundtable
0
1
Dermatology2023-03-29 20:00:00
Are you consistently managing your patients with moderate to severe atopic dermatitis (AD) or treating the flares as they come?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Pulmonary Arterial Hypertension
417
global
1
1.0
1.0
Clinical Review
0
1
Cardiology2023-03-29 20:00:00
Through the lens of SDoH, this program will explore the burdens many PAH patients face including access to care and prejudices real or perceived.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Acute Heart Failure (HF)
6006394
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Cardiology2023-03-29 20:00:00
Preventing rehospitalization for heart failure (HF) is key. Listen as our experts discuss the latest evidence for optimizing medical therapy for better patient outcomes.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Mantle Cell Lymphoma
5000612
global
1
0.5
0.5
Commentary
0
1
Hematology-Oncology2023-03-29 20:00:00
Have you heard about the newest noncovalent Bruton tyrosine kinase (BTK) inhibitor that has been added to the selection of BTK inhibitors used to treat relapsed/refractory (R/R) mantle cell lymphoma (MCL)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
0
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Case
0
1
Hematology-Oncology2023-03-29 20:00:00
How much attention do you pay to the role of caregivers?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Social Determinants of Health
6010999
global
1
0.25
9
0.25
2
0.25
0.25
Roundtable
0
1
Hematology-Oncology2023-03-28 20:00:00
How confident are you at recognizing and addressing inequities in the care of patients with hematologic malignancies?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Breast Cancer
840
global
1
0.75
9
0.75
2
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-28 20:00:00
What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Primary Immunodeficiency
6008790
global
1
0.25
0.25
Clinical Review
0
1
Allergy & Clinical Immunology2023-03-28 20:00:00
Did you know that worldwide between 70% and 90% of people living with a primary immunodeficiency remain undiagnosed?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Aesthetic Medicine
5000574
global
1
0.75
2
0.75
0.75
Commentary
0
1
Plastic Surgery & Aesthetic Medicine2023-03-28 20:00:00
Are you effectively using chemical peels in your practice?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Atrial Fibrillation
390
global
1
0.25
9
0.25
0.25
Clinical Case
0
1
Cardiology2023-03-27 20:00:00
Can symptoms of atrial fibrillation overlap with other conditions? Follow a patient’s journey with expert guidance provided by Dr Kowey.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Cerebrovascular Accident
477
global
1
1.25
1.25
Clinical Review
0
1
Neurology & Neurosurgery2023-03-27 20:00:00
To close, or not to close? Strategies to determine stroke etiology, strengthen multidisciplinary collaboration, and engage patients are revealed here.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Myelofibrosis
5003320
global
1
0.25
9
0.25
0.25
Roundtable
0
1
Hematology-Oncology2023-03-27 20:00:00
Did you know new treatments in development are being developed for myelofibrosis with the goal of changing the disease course?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Ovarian Cancer
839
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-26 20:00:00
Integrating maintenance therapy into treatment for patients with ovarian cancer
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Acute Leukemia
5005273
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-26 20:00:00
Hear updates from the winter meetings on novel approaches for getting older patients with acute myeloid leukemia (AML) to transplant.
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-26 20:00:00
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
